The global transcranial magnetic stimulator market size was valued at USD 883.38 million in 2018 and is anticipated to grow at a CAGR of 8.8% over the forecast period. Increasing prevalence of neurological disorders, such as Alzheimer’s and Parkinson’s disease (PD), along with increasing awareness about TMS among professionals are few factors driving the growth. Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that uses a magnetic field to reduce chronic pain and stimulate nerve cells in the brain. It also improves symptoms of neurological disorders, such as depression. TMS is mainly used for Treatment-resistant Depression (TRD). Many healthcare professionals have reported positive outcomes of this treatment.